Low-dose rapamycin unmasks the protective potential of targeting intragraft NF-κB for islet transplants. [electronic resource]
Producer: 20140829Description: 2355-66 p. digitalISSN:- 1555-3892
- Animals
- Cells, Cultured
- Chemokines -- genetics
- Diabetes Mellitus, Experimental -- mortality
- Drug Synergism
- Graft Survival -- drug effects
- I-kappa B Kinase -- genetics
- Immunosuppressive Agents -- pharmacology
- Intercellular Adhesion Molecule-1 -- genetics
- Interleukin-6 -- genetics
- Islets of Langerhans -- cytology
- Islets of Langerhans Transplantation
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- NF-kappa B -- antagonists & inhibitors
- Sirolimus -- pharmacology
- Swine
- Transplantation, Homologous
- Tumor Necrosis Factor-alpha -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.